A study on the chemical stability of cholesterol-lowering drugs in concomitant simple suspensions with magnesium oxide

Table 1 Reversed-phase HPLC conditions

Formulation	Composition of mobile phase^a (buffer / CH₃CN)	Wavelength (nm)
AS	35 / 65	245
PS	60 / 40	234
RS	45 / 55	242
SS	15 / 85	238
EZ	40 / 60	232

^aTwenty millimolar phosphoric acid-sodium dihydrogen phosphate buffer (pH 2.5) was used

ISSN: 2055-0294